retatrutide clinical use VisualAbstract: reduces body weight by 17.5% in patients with obesity Phase III retatrutide study demonstrates

Potential Benefits Being Studied Significant Weight Reduction Clinical studies have shown that Retatrutide may produce substantial body weight reductions compared with placebo groups

Zepbound is a onceweekly GLP1/GIP injection approved for chronic weight management

Glucagon is most famous for the role it plays in sugar metabolism

This paper aims to summarize the possible mechanism of metformin in relation to gut microbiota

Exploring the relationship between the Mediterranean diet and weight loss maintenance: the MedWeight study

In contrast, insulin therapy, although vital for managing blood glucose, is not typically associated with weight loss